Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Frontiers in Oncology|December 11, 2023
Construction of a prognostic 6-gene signature for breast cancer based on multi-omics and single-cell dataZeyu Xing, Dongcai Lin, Yuting Hong, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2007
Design and optimization of imidazole derivatives as potent CXCR3 antagonistsXiaohui Du, Xiaoqi Chen, Jeffrey T Mihalic, et al.
Materials Today. Bio|September 22, 2025
Bioinspired nanoparticles prevent blue-light-induced skin hyperpigmentation via FZD2-TYR-melanin pathwayXiaoqi Chen, Tong Wu, Zijun Chen, et al.
Chinese Medical Journal|June 12, 2024
Machine-learning-based models assist the prediction of pulmonary embolism in autoimmune diseases: A retrospective, multicenter studyZiwei Hu, Yangyang Hu, Shuoqi Zhang, et al.
Discover Oncology|February 12, 2025
Dynamic changes in peripheral blood immunophenotyping and its prognostic value in cervical cancer patients undergoing immune checkpoint blockade therapyWenjian Gong, Zhi Wang, Yongqiang Wei, et al.
The Journal of Organic Chemistry|November 14, 2007
Stereoselective synthesis of a MCHr1 antagonistDenise Andersen, Thomas Storz, Pingli Liu, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2012
Discovery of a new class of ghrelin receptor antagonistsJeffrey T Mihalic, Yong-Jae Kim, Mike Lizarzaburu, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Imidazo-pyrazine derivatives as potent CXCR3 antagonistsXiaohui Du, Darin J Gustin, Xiaoqi Chen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 21, 2012
Sequential metabolism of AMG 487, a novel CXCR3 antagonist, results in formation of quinone reactive metabolites that covalently modify CYP3A4 Cys239 and cause time-dependent inhibition of the enzymeKirk R Henne, Thuy B Tran, Brooke M VandenBrink, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2011
Discovery of potent and specific CXCR3 antagonistsXiaoqi Chen, Jeff Mihalic, Jeff Deignan, et al.
Pageof 16